当前位置：
X-MOL 学术
›
Eur. J. Clin. Investig.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2021-08-10 , DOI: 10.1111/eci.13663 Chiraphat Kloypan 1, 2, 3 , Matthanaporn Saesong 1 , Juthamat Sangsuemoon 1 , Prawat Chantharit 4 , Pajaree Mongkhon 5, 6
European Journal of Clinical Investigation ( IF 4.4 ) Pub Date : 2021-08-10 , DOI: 10.1111/eci.13663 Chiraphat Kloypan 1, 2, 3 , Matthanaporn Saesong 1 , Juthamat Sangsuemoon 1 , Prawat Chantharit 4 , Pajaree Mongkhon 5, 6
Affiliation
There is still a lack of consensus on the efficacy of convalescent plasma (CP) treatment in COVID-19 patients. We performed a systematic review and meta-analysis to investigate the efficacy of CP vs standard treatment/non-CP on clinical outcomes in COVID-19 patients.
中文翻译：
COVID-19 恢复期血浆：临床试验和真实世界证据的荟萃分析
关于恢复期血浆（CP）治疗 COVID-19 患者的疗效仍缺乏共识。我们进行了系统回顾和荟萃分析，以研究 CP 与标准治疗/非 CP 对 COVID-19 患者临床结果的疗效。
更新日期：2021-10-17
中文翻译：
COVID-19 恢复期血浆：临床试验和真实世界证据的荟萃分析
关于恢复期血浆（CP）治疗 COVID-19 患者的疗效仍缺乏共识。我们进行了系统回顾和荟萃分析，以研究 CP 与标准治疗/非 CP 对 COVID-19 患者临床结果的疗效。
京公网安备 11010802027423号